Selected recent publications by members of the City Health Economics Centre (members' names shown in bold):
Appleby J, Devlin N, Parkin D, Buxton M, Chalkidou K. Searching for cost effectiveness thresholds in the NHS. Health Policy.(Accepted for publication in 2009. Currently available online at journal website: http://dx.doi.org/10.1016/j.healthpol.2008.12.010)
Brooker S, Kabatereine N. Fleming F, Devlin N. Cost and cost effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling up. Health Policy and Planning , 2008; 23:24-35.
Dimakou, S, Parkin, D, Devlin, N, Appleby, J. Identifying the impact of government targets on waiting times in the NHS. Health Care Management Science. (Accepted for publication in 2008. Currently available online at journal website: http://www.springerlink.com/content/a108520738546h2k/)
Flood, C., Bowers, L, Parkin, D. Estimating the Costs of Conflict and Containment on Adult Acute Inpatient Psychiatric Wards. Nursing Economics, September/October 2008; 26 (5)
Bowers, L, Whittington, R, Nolan, P, Parkin, D, Curtis, S, Bhui, K, Hackney, D, Allan, T, Simpson, A. Relationship between service ecology, special observation and self-harm during acute in-patient care: City-128 study. British Journal of Psychiatry, Nov 2008; 193: 395 – 401
Jofre-Bonet, M, Costa-Font, J. Private Health Insurance: The secession of the wealthy? Bulletin of Research Economics, Volume 60 Issue 3, June 2008, Pages 265 – 287.
Jofre-Bonet, M, Nancy M. Petry. Trading apples for oranges? Results of an experiment on the effects of heroin and cocaine price changes on addicts' polydrug use, Journal of Economic Behavior and Organization, Volume 66, Issue 2, May 2008, Pages 281-311.
Appleby J, Devlin N, Parkin D. NICE’s cost effectiveness threshold: how high should it be? British Medical Journal, 2007: 335: 358-359.
Devlin N, Parkin, D. Guidance to users of EQ-5D value sets. In: Szende, A., Oppe, M. and Devlin, N. (Editors) EQ-5D Value Sets: Inventory, Comparative Review and User Guide, 2007, Springer Verlag.
Morris S, Devlin N, Parkin D. Economic Analysis in Health Care, John Wiley & Sons, 2007.
Buckingham K, Devlin N. A theoretical framework for TTO valuations of health. Health Economics, 2006; 15 (10) 1149-54.
Costa-Font J, Jofre-Bonet, M. Are Private Health Insurance Subscribers Unsatisfied with the Spanish National Health System? The Geneva Papers on Risk and Insurance, 2006, volume 31(4): 650-668
Parkin D, Devlin N. Is there a case for using visual analogue scale valuations in Cost Utility Analysis? Health Economics, 2006; 15:653-664.
Appleby, J., Boyle, S., Devlin, N., Harley, M., Harrison, A., Thorlby, R. Do English NHS waiting times targets distort treatment priorities in orthopaedics? Journal of Health Services Research and Policy, 2005; 10(3):167-22.
Ashton, T., Mays, N., Devlin, N. Continuity through change: the rhetoric and reality of health reform in New Zealand. Social Science and Medicine, 2005; 61:253-62
Burge, P., Devlin N., Appleby, J., Rohr, C, Grant, J. Do patients prefer quicker treatment? A discrete choice analysis of patients' stated preferences in the London Patient Choice Project. Journal of Applied Health Economics and Health Policy, 2005; 3(4): 183-194.
Busch, S.H., Jofre-Bonet, M., Falba, T.A. and Sindelar, J.L. Smoking and household expenditure: Is there a crowd-out of other goods? Applied Health Economics and Health Policy, 2005; 3(4)
Dakin, H., Devlin, N., Odeyemi, I. Yes, no or 'yes, but'?: A multinomial model of NICE decision-making. Health Policy (in press).
Devlin, N., Hansen, P., Herbison, P., Macran, S. A 'new and improved' EQ-5D valuation questionnaire? Results from a pilot study. European Journal of Health Economics, 2005; 6(1): 73-82.
Jofre-Bonet, M., Busch S.H., Falba T.A. and Sindelar J.L. Poor Mental Health and Smoking: Interactive Impact on Wage, Journal of Mental Health Policy and Economics, 2005; 8(4): 193-203
Parkin D, Rice N, Jacoby A. Use of a visual analogue scale in a daily patient diary: modelling cross-sectional time-series data on health-related quality of life. Social Science and Medicine, 2004; 59(2): 351-360.
Devlin, N., Hansen, P., Selai, C. Understanding health state valuations: a qualitative analysis of respondents' comments. Quality of Life Research, 2004; 13(7):1265-77.
Devlin N, Parkin D. Does NICE have a cost effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Economics, 2004; 13: 437-452.
Perkins, M., Devlin, N. and Hansen, P. The validity and reliability of EQ-5D health state valuations in a study of Mäori. Quality of Life Research, 2004; 13(1) 271-274
Brisson M., Edmunds W.J. Economic evaluation of vaccination programmes: the impact of herd immunity. Medical Decision Making, 2003; 23 (1): 76-82.
Devlin, N., Hansen, P., Kind, P., Williams, A. Logical inconsistencies in survey respondents' health state valuations - a methodological challenge for estimating social tariffs. Health Economics, 2003; 12(7): 529-544.
Devlin N, Appleby J, Parkin D. Patients' views on explicit rationing: what are the implications for health service decision-making? Journal of Health Services Research and Policy, 2003; 8(3):183-186.
Devlin, N., Gold, M., Parkin, D. WHO evaluates NICE British Medical Journal, 2003; 327: 1061-2.
Devlin N, Parkin D. Funding fertility: Issues in the allocation and distribution of resources to assisted reproduction technologies. Human Fertility, 2003; 6(Supplement): S2-S6.
Garcia-Mariñoso, B., and Jelovac, I. General practitioners' payment contracts and their referral policy Journal of Health Economics, 2003; 22-4, p. 617-635.
Hollingsworth, B. and Parkin, D. Efficiency and productivity change in the English National Health Service: can Data Envelopment Analysis provide a robust and useful measure? Journal of Health Services Research and Policy, 2003; 8(4): 230-236.
Eccles, M, McColl, E, Steen, N, Rousseau, N, Grimshaw, J, Parkin, D and Purves, I. Effect of computerised evidence based guidelines on management of asthma and angina in adults in primary care: cluster randomised controlled trial. British Medical Journal, 2002, 325: 941-946
Parkin, D, Sutton, M and Rice, N. Non- and semi-parametric estimation of age and time heterogeneity in repeated cross-sections: application to self-reported morbidity and General Practitioner utilisation. Jones, A and O'Donnell, O. (Editors) Econometric Analysis of Health Data, 2002, John Wiley and Sons, Chichester. Reprinted from: Health Economics (1999) 8: 429-440.
Parkin D, Devlin N. (2002) Measuring efficiency in dental care. In Scott, A, Maynard, A and Elliott, R. (Editors) Advances in Health Economics, John Wiley and Sons, Chichester, 2002.
Robinson, A, and Parkin, D. Recognising diversity in public preferences: the use of preference sub-groups in cost-effectiveness analysis. A response to Sculpher and Gafni. Health Economics, 2002; 11(7): 649-651.
Towse, A., Devlin, N., Pritchard, C (eds) (2002) Cost effectiveness thresholds: economic and ethical issues. London: Office for Health Economics/King's Fund.
Trotter C.L., Edmunds W.J. The cost-effectiveness of the meningococcal group C conjugate vaccination campaign in England and Wales. British Medical Journal, 2002; 324: 809-12.
Appleby, J., Street, A. (2001) Health System Goals: Life, Death and Football. Journal of Health Services Research and Policy 6(4):220-25.
Devlin, N., Hansen, P. (2001) Health care spending and economic output: Granger causality. Applied Economics Letters 8:561-564.
Edmunds W.J, Brisson M, and Rose J.D. (2001) The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine 19: 3076-3090.
Hollingsworth, B. and Parkin, D. The efficiency of the delivery of neonatal care in the UK. Journal of Public Health Medicine, 2001; 23(1): 47-50
Robinson, A, Thomson, R, Parkin, D, Sudlow, M and Eccles, M. How patients with atrial fibrillation value different health outcomes: a standard gamble study. Journal of Health Services Research and Policy, 2001; 6(2): 92-98.
Appleby, J., Boyle, S. (2000) Blair's Billions: where will he find the money? British Medical Journal 320:865-7.
Parkin, D, McNamee, P, Jacoby, A, Miller, P, Thomas, S and Bates, D. (2000) Treatment of multiple sclerosis with interferon beta: an assessment of cost-effectiveness and quality of life. Journal of Neurology, Neurosurgery and Psychiatry, 2000; 68:144-149.
Thomson, R, Parkin, D, Eccles, M, Sudlow, M and Robinson, R. Decision analysis and guidelines for anticoagulation therapy to prevent stroke in patients with atrial fibrillation. Lancet, 2000; 355:956-962.